Literature DB >> 19527559

Prevalence and correlates of chronic depression in the canadian community health survey: mental health and well-being.

Satyendra Satyanarayana1, Murray W Enns, Brian J Cox, Jitender Sareen.   

Abstract

OBJECTIVE: To determine the prevalence and correlates of chronic depression in comparison with nonchronic depression using a population-representative national database.
METHODS: Our study used data from the Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2) to determine the lifetime prevalence and correlates of major depression with chronic symptoms in the population. The CCHS 1.2 is a large, cross-sectional mental health survey conducted by Statistics Canada (n = 36 984, aged 15 years and older).
RESULTS: The observed lifetime prevalence of major depression with chronic symptoms was 2.7%, representing 26.8% of all people with major depressive disorder (MDD). In comparison to nonchronic major depression, chronic depression was associated with more frequent psychiatric and medical comorbidity, greater disability, increased health service use, and higher likelihood of suicidal ideation and attempts.
CONCLUSIONS: Major depression with chronic symptoms is common in the general population, and is associated with more severe health consequences than nonchronic depression. These observations indicate that chronic major depression is a very important subtype of MDD from a public health perspective.

Entities:  

Mesh:

Year:  2009        PMID: 19527559     DOI: 10.1177/070674370905400606

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  23 in total

1.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02

2.  Suicidal behaviours in adolescents in Nova Scotia, Canada: protective associations with measures of social capital.

Authors:  Donald B Langille; Mark Asbridge; Steve Kisely; Daniel Rasic
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-12-27       Impact factor: 4.328

3.  Cognitive Therapy to Prevent Depressive Relapse in Adults.

Authors:  Jeffrey R Vittengl; Robin B Jarrett
Journal:  Curr Opin Psychol       Date:  2015-08-01

4.  Associations of School Connectedness With Adolescent Suicidality: Gender Differences and the Role of Risk of Depression.

Authors:  Donald B Langille; Mark Asbridge; Amber Cragg; Daniel Rasic
Journal:  Can J Psychiatry       Date:  2015-06       Impact factor: 4.356

5.  Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.

Authors:  Lena Sabaß; Frank Padberg; Claus Normann; Vera Engel; Carsten Konrad; Kristina Helmle; Andrea Jobst; Andrew Worlitz; Eva-Lotta Brakemeier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-27       Impact factor: 5.270

6.  Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.

Authors:  Andrew W Roberts; Stacie B Dusetzina; Joel F Farley
Journal:  J Comp Eff Res       Date:  2015-01       Impact factor: 1.744

7.  Expanding stress generation theory: test of a transdiagnostic model.

Authors:  Christopher C Conway; Constance Hammen; Patricia A Brennan
Journal:  J Abnorm Psychol       Date:  2012-03-19

8.  Telephone counseling for patients with chronic heart failure: results of an evaluation study.

Authors:  Sylvia Böhme; Christian Geiser; Thomas Mühlenhoff; Jana Holtmann; Babette Renneberg
Journal:  Int J Behav Med       Date:  2012-09

9.  Persistent Depression as a Novel Diagnostic Category: Results from the Menderes Depression Study.

Authors:  Saliha Ildirli; Yaşan Bilge Şair; Ferhan Dereboy
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

10.  [Guideline-conform inpatient psychiatric psychotherapeutic treatment of chronic depression: Normative personnel requirements].

Authors:  K Schnell; A Hochlehnert; M Berger; J Wolff; M Radtke; E Schramm; C Normann; S C Herpertz
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.